Thoracic Aortic Stent Grafts Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$2500
Buy Report Download FREE Resources

Published: November 27, 2024 Report Code: GDME1891EPD-ST

Select Item

Thoracic Aortic Stent Grafts Pipeline Market Report Overview

Thoracic aortic stent grafts are used to treat thoracic aortic aneurysms by reinforcing a part of the aorta using a minimally invasive procedure. The thoracic aortic stent grafts pipeline market research report covers comprehensive information about the pipeline products with their comparative analysis at various stages of development. The report also includes information about the clinical trials which are in progress.

Key Territories ·       The US

·       Europe

·       China

·       Japan

·       Canada
Key Regulatory Paths ·       PMA

·       CE

·       NMPA

·       Shonin

·       MDL
Leading Companies ·       APT Medical Inc

·       Artivion Inc

·       EndoSpan Ltd

·       Evasc Medical Systems Corp

·       Hangzhou Endonom Medtech Co Ltd
Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Thoracic Aortic Stent Grafts Pipeline Market Segmentation by Territories

The key territories in the thoracic aortic stent grafts pipeline market are the US, Europe, China, Japan, and Canada, among others. As of November 2024, the US accounted for the highest number of pipeline products.

Thoracic Aortic Stent Grafts Pipeline Market Analysis by Territories, 2024 (%)

Thoracic Aortic Stent Grafts Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Thoracic Aortic Stent Grafts Pipeline Market

Download a Free Report Sample

Thoracic Aortic Stent Grafts Pipeline Market Segmentation by Regulatory Paths

The key regulatory paths in the thoracic aortic stent grafts pipeline products market are PMA, CE, NMPA, Shonin, and MDL, among others. As of November 2024, PMA was the most followed pathway for pipeline products in the thoracic aortic stent grafts market.

Thoracic Aortic Stent Grafts Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Thoracic Aortic Stent Grafts Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Thoracic Aortic Stent Grafts Pipeline Market

Download a Free Report Sample

Thoracic Aortic Stent Grafts Pipeline Market – Competitive Landscape

A few of the leading companies associated with the thoracic aortic stent grafts pipeline market are:

  • APT Medical Inc
  • Artivion Inc
  • EndoSpan Ltd
  • Evasc Medical Systems Corp
  • Hangzhou Endonom Medtech Co Ltd


APT Medical Inc: APT Medical Inc is a medical device manufacturing company that develops and supplies electrophysiology and vascular intervention devices. Its product portfolio includes catheters, diagnostic and therapeutic products, snare kit, and guidewires. Furthermore, it includes nitinol products in cardiology, neurology and urology. The company is headquartered in Shenzhen, Guangdong, China.

Artivion Inc: Headquartered in Kennesaw, Georgia, the US, Artivion Inc, formerly CryoLife Inc, is a medical device company. It specializes in the manufacturing, processing, and distribution of medical devices and implantable human tissues. The company’s product portfolio includes aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion’s products are primarily used in cardiac and vascular surgeries, catering to patients with aortic conditions. The company markets its products and preservation services directly to physicians in the US and Canada and utilizes independent distributors and subsidiaries in the EMEA, APAC, and LATAM regions.

EndoSpan Ltd: EndoSpan Ltd (EndoSpan) is a developer of an aortic stent-grafts system designed to treat aneurysms, dissections and aortic lesions that offers invasive endovascular services and differentiated aortic endografts. EndoSpan is headquartered in Herzliya, Israel.

Thoracic Aortic Stent Grafts Pipeline Market Analysis by Companies, 2024

Thoracic Aortic Stent Grafts Pipeline Market Analysis by Companies, 2024

Buy the Full Report for More Company Insights into the Thoracic Aortic Stent Grafts Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Thoracic Aortic Stent Grafts Pipeline Market Territories Outlook (2024)

  • The US
  • Europe
  • China
  • Japan
  • Canada

Thoracic Aortic Stent Grafts Pipeline Market Regulatory Paths Outlook (2024)

  • PMA
  • CE
  • NMPA
  • Shonin
  • MDL

Scope

This report provides:

  • Extensive coverage of the thoracic aortic stent grafts under development.

  • Details of major pipeline products which include product description, licensing and collaboration details, and other developmental activities.

  • Reviews of major players involved in the development of thoracic aortic stent grafts and lists of all their pipeline projects.

  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.

  • Key clinical trial data of ongoing clinical trials specific to pipeline products.

  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.

  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain competitive advantage.

  • Identify and understand important and diverse types of thoracic aortic stent grafts under development.

  • Develop market-entry and market-expansion strategies.

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.

  • Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.

APT Medical Inc
Artivion Inc
Beijing Tianzhu Ruichang Medical Technology Co Ltd
EndoSpan Ltd
Evasc Medical Systems Corp
Hangzhou Endonom Medtech Co Ltd
JOTEC GmbH
Lombard Medical Technologies Inc.
Medtronic Plc
Sree Chitra Tirunal Institute for Medical Sciences & Technology
St. Jude Medical LLC
Terumo Aortic
The Lundquist Institute
TriVascular Inc
University of Kentucky
Zylox-Tonbridge Medical Technology Co Ltd

Table of Contents

  • 1. 1 Table of Contents

    • 1.1. List of Tables

    • 1.2. List of Figures

  • 2. Introduction

    • 2.1. Thoracic Aortic Stent Grafts Overview

  • 3. Products under Development

    • 3.1. Thoracic Aortic Stent Grafts – Pipeline Products by Stage of Development

    • 3.2. Thoracic Aortic Stent Grafts – Pipeline Products by Territory

    • 3.3. Thoracic Aortic Stent Grafts – Pipeline Products by Regulatory Path

    • 3.4. Thoracic Aortic Stent Grafts – Pipeline Products by Estimated Approval Date

    • 3.5. Thoracic Aortic Stent Grafts – Ongoing Clinical Trials

  • 4. Thoracic Aortic Stent Grafts – Pipeline Products under Development by Companies

    • 4.1. Thoracic Aortic Stent Grafts Companies – Pipeline Products by Stage of Development

    • 4.2. Thoracic Aortic Stent Grafts – Pipeline Products by Stage of Development

  • 5. Thoracic Aortic Stent Grafts Companies and Product Overview

    • 5.1. APT Medical Inc Company Overview

      • 5.1.1. APT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.2. Artivion Inc Company Overview

      • 5.2.1. Artivion Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.3. Beijing Tianzhu Ruichang Medical Technology Co Ltd Company Overview

      • 5.3.1. Beijing Tianzhu Ruichang Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.4. EndoSpan Ltd Company Overview

      • 5.4.1. EndoSpan Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.5. Evasc Medical Systems Corp Company Overview

      • 5.5.1. Evasc Medical Systems Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.6. Hangzhou Endonom Medtech Co Ltd Company Overview

      • 5.6.1. Hangzhou Endonom Medtech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.7. JOTEC GmbH Company Overview

      • 5.7.1. JOTEC GmbH Pipeline Products & Ongoing Clinical Trials Overview

    • 5.8. Lombard Medical Technologies Inc. Company Overview

      • 5.8.1. Lombard Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview

    • 5.9. Medtronic Plc Company Overview

      • 5.9.1. Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.10. Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview

      • 5.10.1. Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview

    • 5.11. St. Jude Medical LLC Company Overview

      • 5.11.1. St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.12. Terumo Aortic Company Overview

      • 5.12.1. Terumo Aortic Pipeline Products & Ongoing Clinical Trials Overview

    • 5.13. The Lundquist Institute Company Overview

      • 5.13.1. The Lundquist Institute Pipeline Products & Ongoing Clinical Trials Overview

    • 5.14. TriVascular Inc Company Overview

      • 5.14.1. TriVascular Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.15. University of Kentucky Company Overview

      • 5.15.1. University of Kentucky Pipeline Products & Ongoing Clinical Trials Overview

    • 5.16. Zylox-Tonbridge Medical Technology Co Ltd Company Overview

      • 5.16.1. Zylox-Tonbridge Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

  • 6. Thoracic Aortic Stent Grafts- Recent Developments

    • 6.1. Oct 31, 2024: LeMaitre Reports Q3 2024 Results

    • 6.2. Oct 08, 2024: Merit Medical Systems to Announce Third Quarter 2024 Results on October 30, 2024

    • 6.3. Aug 30, 2024: MicroPort Scientific Reports Earnings Results for the Half Year Ended June 30, 2024

    • 6.4. Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference

    • 6.5. Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference

    • 6.6. Aug 01, 2024: Merit Medical Systems Announces Q2 2024 Results and Raises Full-Year Guidance

    • 6.7. Jun 18, 2024: Merit Medical Systems to Announce Second Quarter 2024 Results on August 1, 2024

    • 6.8. Jun 13, 2024: Medtronic Confirms Global Layoffs

    • 6.9. Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference

  • 7. Appendix

    • 7.1. Methodology

    • 7.2. About GlobalData

    • 7.3. Contact Us

    • 7.4. Disclaimer

Table

Thoracic Aortic Stent Grafts – Pipeline Products by Stage of Development

Thoracic Aortic Stent Grafts – Pipeline Products by Territory

Thoracic Aortic Stent Grafts – Pipeline Products by Regulatory Path

Thoracic Aortic Stent Grafts – Pipeline Products by Estimated Approval Date

Thoracic Aortic Stent Grafts – Ongoing Clinical Trials

Thoracic Aortic Stent Grafts Companies – Pipeline Products by Stage of Development

Thoracic Aortic Stent Grafts – Pipeline Products by Stage of Development

APT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

Thoracic Aortic Stent – Product Status

Thoracic Aortic Stent – Product Description

Artivion Inc Pipeline Products & Ongoing Clinical Trials Overview

Neo 2.0 – Product Status

Neo 2.0 – Product Description

Beijing Tianzhu Ruichang Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Three-Branch Thoracic Aorta Stent Graft System – Product Status

Three-Branch Thoracic Aorta Stent Graft System – Product Description

EndoSpan Ltd Pipeline Products & Ongoing Clinical Trials Overview

Nexus Aortic Arch Stent Graft System – Product Status

Nexus Aortic Arch Stent Graft System – Product Description

EndoSpan Ltd – Ongoing Clinical Trials Overview

Nexus Aortic Arch Stent Graft System – A Multi-arm, Multi-center, Non-randomized, Prospective, Clinical Study to Evaluate the Safety and Effectiveness of the NEXUS Aortic Arch Stent Graft System in Treating Thoracic Aortic Lesions Involving the Aortic Arch

Nexus Aortic Arch Stent Graft System – A Non-Randomized, Prospective or Retrospective, Open-Label, Multi-Center, Observational Clinical Study With Two Arms to Further Evaluate Safety and Performance of the NEXUS® Aortic Arch Stent Graft System and the Custom-Made NEXUS DUO™ Aortic Arch Stent Graft System

Nexus Aortic Arch Stent Graft System – ENDOBARC-S Study: “Endovascular Branched Stent-grafts for Aortic ARCh Pathologies in Spain”

Evasc Medical Systems Corp Pipeline Products & Ongoing Clinical Trials Overview

TAS System – Product Status

TAS System – Product Description

Hangzhou Endonom Medtech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

WeFlow-Tbranch Stent Graft System – Product Status

WeFlow-Tbranch Stent Graft System – Product Description

Hangzhou Endonom Medtech Co Ltd – Ongoing Clinical Trials Overview

WeFlow-Tbranch Stent Graft System – Guo’s Aortic Arch Reconstruction: A Multicenter, Prospective Study of the Novel WeFlow-Tribranch Unique Embedded Aortic Triple-branch Arch Stent Graft System (GENIUS Study)

WeFlow-Tbranch Stent Graft System – Guo’s Endovascular Aortic Arch Replacement of Aortic Dissection by WeFlow-Tribranch Endoprothesis: A Multicenter Pilot Study (Graft Study)

WeFlow-Tbranch Stent Graft System – Guo’s Subclavian Artery Reconstruction: The Prospective, Multiple Center Study of WeFlow-Tbranch Stent Graft System (GUEST Study)

WeFlow-Tbranch Stent Graft System – New Technology Clinical Study on the Safety and Efficacy of WeFlow-Tribranch Aortic Arch Stent Graft System in the Treatment of Patients with Aortic Arch Dissection

JOTEC GmbH Pipeline Products & Ongoing Clinical Trials Overview

E-Vita Open Neo – Product Status

E-Vita Open Neo – Product Description

JOTEC GmbH – Ongoing Clinical Trials Overview

E-Vita Open Neo – A Post-market Clinical Follow-up Study in Patients with Acute or Chronic Aortic Dissection or Aortic Aneurysm Treated with E-vita OPEN NEO: NEOS

E-Vita Open Neo – NEO – E-vita Open Neo Treatment of Aortic Arch Aneurysms and Dissections

E-Vita Open Neo – NEOS-APAC – Asian Pacific Post-market Clinical Follow-up Study in Patients with Acute or Chronic Aortic Dissection or Aortic Aneurysm Treated with E-vita OPEN NEO

Lombard Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview

TEVAR – Product Status

TEVAR – Product Description

Lombard Medical Technologies Inc. – Ongoing Clinical Trials Overview

TEVAR – Scandinavian Trial of Uncomplicated Aortic Dissection Therapy

Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview

Valiant Mona LSA System – Product Status

Valiant Mona LSA System – Product Description

Valiant TAAA Stent Graft System – Product Status

Valiant TAAA Stent Graft System – Product Description

Medtronic Plc – Ongoing Clinical Trials Overview

Valiant TAAA Stent Graft System – Visceral Manifold and Unitary Device Study for the Repair of Thoracoabdominal Aortic Aneurysms

Valiant TAAA Stent Graft System – Visceral Manifold Study for the Repair of Thoracoabdominal Aortic Aneurysms

Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview

Aortic Stent Graft – Product Status

Aortic Stent Graft – Product Description

St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview

Amplatzer TAA Vascular Graft – Product Status

Amplatzer TAA Vascular Graft – Product Description

Terumo Aortic Pipeline Products & Ongoing Clinical Trials Overview

RelayBranch Thoracic Stent-Graft System – Product Status

RelayBranch Thoracic Stent-Graft System – Product Description

RelayPro Thoracic Stent-Graft System – Acute Complicated Type B Thoracic Aortic Dissection – Product Status

RelayPro Thoracic Stent-Graft System – Acute Complicated Type B Thoracic Aortic Dissection – Product Description

RelayPro Thoracic Stent-Graft System – Blunt Traumatic Aortic Injury – Product Status

RelayPro Thoracic Stent-Graft System – Blunt Traumatic Aortic Injury – Product Description

Terumo Aortic – Ongoing Clinical Trials Overview

RelayBranch Thoracic Stent-Graft System – A Prospective, Multicenter, Non-blinded, Non-randomized Early Feasibility Study of the Relay Branch Thoracic Stent-graft System in Subjects with Thoracic Aortic Pathologies Requiring Treatment Proximal to the Origin of the Innominate Artery

RelayBranch Thoracic Stent-Graft System – Cerebral Hemodynamics and Microemboli During Placement of RelayBranch Thoracic Stent-Graft System

RelayBranch Thoracic Stent-Graft System – ENDOBARC-S Study: “Endovascular Branched Stent-grafts for Aortic ARCh Pathologies in Spain”

RelayPro Thoracic Stent-Graft System – Acute Complicated Type B Thoracic Aortic Dissection – Thoraflex Hybrid and Relay Extension Post-Approval Study

The Lundquist Institute Pipeline Products & Ongoing Clinical Trials Overview

Thoracic-Abdominal Endoluminal Graft – Product Status

Thoracic-Abdominal Endoluminal Graft – Product Description

TriVascular Inc Pipeline Products & Ongoing Clinical Trials Overview

Ovation Thoracic Stent Graft System – Product Status

Ovation Thoracic Stent Graft System – Product Description

University of Kentucky Pipeline Products & Ongoing Clinical Trials Overview

Endograft – Product Status

Endograft – Product Description

Zylox-Tonbridge Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Thoracic Aorta Stent Graft System – Product Status

Thoracic Aorta Stent Graft System – Product Description

Glossary

Figures

Thoracic Aortic Stent Grafts – Pipeline Products by Stage of Development

Thoracic Aortic Stent Grafts – Pipeline Products by Territory

Thoracic Aortic Stent Grafts – Pipeline Products by Regulatory Path

Thoracic Aortic Stent Grafts – Pipeline Products by Estimated Approval Date

Thoracic Aortic Stent Grafts – Ongoing Clinical Trials

Frequently asked questions

Thoracic Aortic Stent Grafts Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports
Currency USD
$2,500

Can be used by individual purchaser only

Most Popular
$5,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Thoracic Aortic Stent Grafts Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Thoracic Aortic Stent Grafts reports
Medical Devices
New
Global M&A Deals in H1 2026 - Top Themes by…
$495 | August 2026
Medical Devices
New
Medical Devices M&A Deals H1 2026 - Top Themes: Strategic…
$495 | July 2026
Medical Devices
New
AI-designed Materials: Market Trends and Innovations
$995 | July 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Thoracic Aortic Stent Grafts Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Thoracic Aortic Stent Grafts Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more